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http://dx.doi.org/10.1016/j.pedneo.2Tuberous sclerosis complex (TSC) is a multisystem disorder resulting in hamartomatous lesions.
Despite diverse manifestations, skeletal muscular comorbidity is rarely reported in TSC. We re-
port a 2-year-old girl with TSC who suffered from multiple subcutaneous masses over the para-
spinal and bilateral scapular areas, which caused disabling pain on any passive movement.
Three-dimensional computed tomography scanning revealed multiple calcifications that were
consequently diagnosed as fibrodysplasia ossificans progressiva. Such imaging features should
be evaluated cautiously to avoid unnecessary surgical intervention and biopsy that may worsen
the condition.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Tuberous sclerosis complex (TSC) is a multisystem disorder,
characterized by formation of hamartomas in several or-
gans, which primarily affect the skin, brain, heart, kidneys,
lungs, and eyes.1 TSC can be caused by mutations in eithert of Pediatrics, Chung Shan
10, Section 1, Jianguo North
hinet.net (J.-D. Tsai).
an Pediatric Association. Publish
012.12.002the TSC1 gene on chromosome 9q34 encoding hamartin or
the TSC2 gene on chromosome 16p13.3 encoding tuberin.
Hamartin and tuberin function as a complex that is involved
in the control of cell growth and cell division. Thus, mu-
tations at the TSC1 and TSC2 loci result in a loss of control
of cell growth and cell division, and therefore a predispo-
sition to forming hamartomas.2,3
Fibrodysplasia ossificans progressiva (FOP) is a severely
disabling disorder of connective tissue characterized by
progressive heterotopic ossification (HO) that forms qual-
itatively normal bone in characteristic extraskeletal sites.4ed by Elsevier Taiwan LLC. All rights reserved.
66 T.-K. Tan et alSoft tissue ossification is the characteristic radiographic
feature of FOP, and radiographic and bone scan findings
suggest normal modeling and remodeling of heterotopic
bone.5 Computed tomography and magnetic resonance
imaging of early lesions have been described,6,7 and the
definitive diagnosis of FOP can be made by simple clinical
evaluation of progressively ossifying soft tissue lesions.8 To
the best of our knowledge, so far no study has described
TSC in association with HO.Figure 2 Three-dimensional reconstructed computed to-
mography scan of the back and shoulder showing heterotopic
ossification features.2. Case Report
A 2-year-old girl was born to nonconsanguineous healthy
parents. She was diagnosed with an intracardiac mass
prenatally, and overt multiple hypomelanotic patches were
noted after birth. Brain magnetic resonance imaging
revealed cortical tubers and subependymal nodules, which
were evidence of TSC. On follow-up, she was noted to have
had a complex partial seizure at 8 months of age and global
developmental delay in infancy. At 2 years of age, she
suffered from multiple subcutaneous masses over the par-
aspinal and bilateral scapular areas, which caused disabling
pain on any passive movement for 1 month. It was char-
acterized as firm, immovable flare-up without any limita-
tion in joint movement. The descriptive pattern of ongoing
pain was limited possibly due to her global developmental
delay and young age. Initial magnetic resonance imaging of
muscles showed moderate inhomogeneous masses and
a high signal over the affected areas (Figure 1). Excisional
sections of muscle biopsy, which were obtained from the
mass over the affected area, as specimens were stained
with hematoxylin and eosin. The pathologic report of the
biopsy showed neurofibers admixed with adipose tissue.
Routine laboratory tests, including biochemical evaluations
of bone mineral metabolism, were normal. A subsequent
three-dimensional computed tomography scan, performed
because of ongoing pain, revealed multiple calcifications
that were consequently diagnosed as FOP (Figure 2). She
was managed palliatively with Chinese herbs for the intra-
muscular calcification.Figure 1 T1-weighted magnetic resonance image at pre-
sentation revealed multiple inhomogeneous mass and high
signals over the paraspinal area (white arrows).3. Discussion
Both TSC and FOP are rare genetic disorders; however, no
gene locus is shared by these two diseases. The diagnosis is
based on the presence of major and/or minor features of the
diseases. Despite variable and multisystem manifestations,
muscular complications of TSC are rare, particularly in the
musculoskeletal system.9 Only a limited number of articles
have reported muscular lesions in TSC involving the primary
smooth and cardiac muscles, including renal angiomyolipo-
mas, pulmonary lymphangiomyomatosis, and rhabdomyo-
mas. To date, skeletal muscular comorbidity has not been
reported.
HO is a severe, rare condition of the skeletal muscles,
mostly seen in FOP. It is commonly misdiagnosed, as clini-
cians often fail to associate the rapidly developing soft
tissue swellings that appear on the head, neck, and upper
back with malformed great toes.10 The correct diagnosis of
FOP can be made clinically prior to observing radiographic
features of HO if rapidly waxing and waning soft tissue le-
sions are associated. In the absence of such associations,
FOP is commonly misdiagnosed.11 The pathophysiology of
Tuberous sclerosis complex and heterotopic ossification 67TSC and FOP is different. FOP is multifocal, usually starting
to develop after traumatic injury.12 It is supposed to result
from dysregulated bone morphogenetic proteins, which are
members of the transforming growth factor-beta super-
family and play a role in the development of bone and other
tissues.13
Medical intervention for FOP is supportive and palliative.
Guidelines for symptomatic management of disease high-
light the anecdotal utility of glucocorticoids and non-
steroidal anti-inflammatory drugs in managing chronic
discomfort and ongoing flare-ups.14 Surgical release of joint
contractures is generally unsuccessful and risky for new
trauma-induced HO, and osteotomy or surgical removal of
heterotopic bone to mobilize joints will generally cause the
development of additional HO at the operative site.15 Re-
petitive trauma is the most important exacerbating factor
of the disease; therefore, avoiding unnecessary trauma or
surgical procedure can minimize originating or exacer-
bation of the inflammatory processes of FOP, which pre-
cede ectopic calcifications.
The limitation of this report is a lack of genetic evidence
for TSC and FOP. Even though it is more commonly assessable
in TSC, the cost of testing for FOP is too high for the parents.
The options for FOP management remain limited in the case
of either medical or surgical intervention. Imaging features
should be evaluated cautiously to avoid unnecessary surgical
intervention and biopsy that may worsen the condition.
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